Clinical Trials Logo

Clinical Trial Summary

The Myotubular and Centronuclear Myopathy Patient Registry (also referred to as the 'MTM and CNM Registry') is an international, patient-reported database specific to these conditions. More details and online registration are available at www.mtmcnmregistry.org.


Clinical Trial Description

The Myotubular and Centronuclear Myopathy (MTM & CNM) Patient Registry is managed and operated by the John Walton Muscular Dystrophy Research Centre at Newcastle University, in partnership with the Myotubular Trust, and is part of the TREAT-NMD Neuromuscular Network. The registry has been developed in partnership with a number of leading neuromuscular researchers, and is jointly funded by the Myotubular Trust and Muscular Dystrophy UK. Participants register online and must provide consent before accessing the registry questionnaire. The clinical data and genetic or biopsy reports are provided by the participants and their doctors. The MTM & CNM Registry aims to: - Help identify patients for relevant clinical trials as they become available. - Encourage further research into myotubular and centronuclear myopathy. - Provide researchers with specific patient information to support their research. - Assist doctors and other health professionals by providing them with up-to-date information on managing myotubular and centronuclear myopathy, to help them deliver better standards of care for their patients. The investigators welcome the registration of: - All patients with a myotubular myopathy or centronuclear myopathy diagnosis, which has been confirmed via genetic testing or muscle biopsy. - Any carrier females of x-linked myotubular myopathy, especially if they have manifested myotubular myopathy type symptoms. - Any patient who is deceased, but who had a confirmed diagnosis. This is an online registry and is hosted on the RDRF (Rare Disease Registry Framework) by Murdoch University. More details and online registration are available at www.mtmcnmregistry.org. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04064307
Study type Observational [Patient Registry]
Source Newcastle-upon-Tyne Hospitals NHS Trust
Contact Jo Bullivant
Phone 0044 191 241 8640
Email joanne.bullivant@newcastle.ac.uk
Status Recruiting
Phase
Start date March 26, 2013
Completion date December 2022

See also
  Status Clinical Trial Phase
Withdrawn NCT04977648 - Natural History Study of Patients With Centronuclear Myopathies
Enrolling by invitation NCT05099107 - Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment N/A
Completed NCT03351270 - Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies N/A
Recruiting NCT05982119 - Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study N/A
Terminated NCT04033159 - Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies Phase 1/Phase 2
Withdrawn NCT04743557 - Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies Phase 1/Phase 2
Not yet recruiting NCT06157268 - The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.
Recruiting NCT00272883 - Molecular and Genetic Studies of Congenital Myopathies